Genetic testing service

The Liverpool Women's NHS Foundation Trust has recently completed a procurement process for a genetic testing service, titled "Genetic testing service," located in Liverpool, United Kingdom. This process, under the procurement category of services, involved direct procurement below the threshold without competition. The tender was finalised on 8th August 2025, following the signing of the contract on 30th June 2025, and covers a period from 1st July 2025 to 30th June 2026.

The buyer, represented by the Liverpool Women's NHS Foundation Trust, sought to acquire medical analysis services, and the procurement aligns with the legal basis set by UK legislation 2023/54. This contract presents opportunities for businesses within the medical and genetic testing industry to gauge the market's demands and develop services aligned with the public sector's needs. Large enterprises like Igenomix UK Ltd, which successfully secured the contract, demonstrate the potential for business expansion by engaging with public health organisations.

Companies specialising in innovative medical analysis and tissue sampling services could thrive in competing for similar contracts, enhancing their growth and operational reach within the healthcare sector.